To assess the relevance of our experimental findings in human colon cancer, we evaluated the prognostic value of the β2-chimaerin gene (CHN2) expression using a large clinical microarray database of colon cancer patients via the Kaplan–Meier plotter tool [40]. This evidence concerns the gene CHN2 and malignant colon neoplasm.